seekingalpha.com
/1 month ago
Latest updates for Pcrx
Fresh curated links around PCRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Pacira BioSciences: Reimbursement Is Turning An Old Franchise Into A New Growth Platform
- Pacira (PCRX) Q2 2026 Earnings Call Transcript
- Recursion Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
fool.com
/4 weeks ago
Pacira (PCRX) Q2 2026 Earnings Call Transcript
EXPAREL revenue grew 3% while company divested iovera and expanded insurance coverage.
seekingalpha.com
/4 weeks ago
Recursion Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
seekingalpha.com
/1 month ago
Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions
fool.com
/4 weeks ago
Recursion (RXRX) Q2 2026 Earnings Call Transcript
AI-native drug discovery advances neuroscience target with Roche while cutting cash guidance.
seekingalpha.com
/1 month ago
Pyxis Oncology: The Market Might Have Already Ruled On Micvotabart Pelidotin
seekingalpha.com
/1 month ago
RXO: Expectations Seem Imaginary As Core Metrics Worsen In Q2
seekingalpha.com
/2 weeks ago
Royalty Pharma: The Quiet Compounder The Market Is Still Mispricing
cafepharma.com
/1 week ago
BioXcel
BioXcel Anonymous (not verified) Sun, 08/30/2026 - 09:43 field_thread_url https://cafepharma.com/boards/threads/bioxcel.674502/ board na...
seekingalpha.com
/3 weeks ago
Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M
seekingalpha.com
/4 weeks ago
RXO, Inc. (RXO) Presents at Deutsche Bank's Chicago Industrials Summit Transcript
fool.com
/4 weeks ago
Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript
Royalty receipts surged 14% as guidance raised for second consecutive quarter.
fool.com
/4 weeks ago
Perrigo (PRGO) Q2 2026 Earnings Call Transcript
Market share gains offset sales decline as Perrigo completes Dermacosmetics divestiture.
seekingalpha.com
/1 month ago
Privia Health Group, Inc. 2026 Q2 - Results - Earnings Call Presentation
seekingalpha.com
/1 month ago
Pacific Biosciences of California, Inc. 2026 Q2 - Results - Earnings Call Presentation
seekingalpha.com
/4 weeks ago
Peraso Inc. 2026 Q2 - Results - Earnings Call Presentation
cafepharma.com
/1 week ago
Praxis
Praxis Anonymous (not verified) Tue, 09/01/2026 - 12:45 field_thread_url https://cafepharma.com/boards/threads/praxis.717326/ board name...
cafepharma.com
/1 week ago
Praxis
Praxis Anonymous (not verified) Mon, 08/31/2026 - 12:44 field_thread_url https://cafepharma.com/boards/threads/praxis.717326/ board name...
seekingalpha.com
/2 weeks ago
Royalty Pharma: Strong Execution, Higher Guidance, And Room For A Re-Rating
seekingalpha.com
/4 hours ago
Arcus Biosciences, Inc. (RCUS) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
seekingalpha.com
/3 weeks ago
ARS Pharmaceuticals, Inc. (SPRY) Q2 2026 Earnings Call Transcript
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Pcrx
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source